Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Acute Adrenal Insufficiency Precipitated by the Discontinuation of a Betamethasone and Dextrochlorpheniramine Combination: The Diagnostic Utility of an Echocardiographic Assessment of Systemic Vascular Resistance.

Mukai J, Mori S, Katsumori-Yoshimura Y, Takeshige R, Tabata T, Imada H, Shimoura H, Takahashi H, Takahashi Y, Hirata KI.

Intern Med. 2019 Jul 15;58(14):2045-2049. doi: 10.2169/internalmedicine.2502-18. Epub 2019 Apr 17.

2.

Combined assessment of left atrial volume parameters for predicting recurrence of atrial fibrillation following pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Soga F, Tanaka H, Mochizuki Y, Mukai J, Suto M, Takada H, Hatani Y, Matsuzoe H, Hatazawa K, Sano H, Ooka J, Shimoura H, Matsumoto K, Fukuzawa K, Hirata KI.

Echocardiography. 2019 May;36(5):862-869. doi: 10.1111/echo.14315. Epub 2019 Mar 25.

PMID:
30908731
3.

Echocardiography during preload stress for evaluation of right ventricular contractile reserve and exercise capacity in pulmonary hypertension.

Sano H, Tanaka H, Motoji Y, Mukai J, Suto M, Takada H, Soga F, Hatani Y, Matsuzoe H, Hatazawa K, Shimoura H, Ooka J, Nakayama K, Matsumoto K, Yamada H, Emoto N, Hirata KI.

Echocardiography. 2018 Dec;35(12):1997-2004. doi: 10.1111/echo.14161. Epub 2018 Oct 16.

PMID:
30328154
4.

Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.

Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.

Ann Nutr Metab. 2018;73(3):227-233. doi: 10.1159/000492940. Epub 2018 Sep 13.

PMID:
30212820
5.

Alterations in Pharmacokinetics of Orally Administered Carbamazepine in Rats Treated with Sodium alginate: Possible Interaction between Therapeutic Drugs and Semi-solid Enteral Nutrients.

Nagai K, Omotani S, Ito A, Nishimura I, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.

Drug Res (Stuttg). 2019 Feb;69(3):168-172. doi: 10.1055/a-0662-5701. Epub 2018 Aug 13.

PMID:
30103217
6.

Quetiapine-related Acute Kidney Injury Requiring Transient Continuous Hemodiafiltration.

Yamada H, Katsumori Y, Kawano M, Mori S, Takeshige R, Mukai J, Imada H, Shimoura H, Takahashi H, Horai T, Okita Y, Hirata KI.

Intern Med. 2018 Jun 15;57(12):1763-1767. doi: 10.2169/internalmedicine.0170-17. Epub 2018 Feb 9.

7.

Bactericidal effects of deep ultraviolet light-emitting diode for solutions during intravenous infusion.

Omotani S, Tani K, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.

Int J Med Sci. 2018 Jan 1;15(2):101-107. doi: 10.7150/ijms.22206. eCollection 2018.

8.

In vitro and in vivo effects of selected fibers on the pharmacokinetics of orally administered carbamazepine: Possible interaction between therapeutic drugs and semisolid enteral nutrients.

Nagai K, Omotani S, Otani M, Sasatani M, Takashima T, Hatsuda Y, Mukai J, Myotoku M.

Nutrition. 2018 Feb;46:44-47. doi: 10.1016/j.nut.2017.08.006. Epub 2017 Aug 10.

PMID:
29290355
9.

Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus.

Ebara S, Marumo M, Mukai J, Ohki M, Uchida K, Wakabayashi I.

J Thromb Thrombolysis. 2018 Feb;45(2):200-205. doi: 10.1007/s11239-017-1594-x.

PMID:
29247447
10.

Impact of overweight on left ventricular function in type 2 diabetes mellitus.

Suto M, Tanaka H, Mochizuki Y, Mukai J, Takada H, Soga F, Dokuni K, Hatani Y, Hatazawa K, Matsuzoe H, Sano H, Shimoura H, Ooka J, Matsumoto K, Hirota Y, Ogawa W, Hirata KI.

Cardiovasc Diabetol. 2017 Nov 9;16(1):145. doi: 10.1186/s12933-017-0632-5.

11.

Cardiac apical swinging detected by computed tomography.

Takeshige R, Mori S, Nishii T, Mukai J, Watanabe Y, Shimoyama S, Izawa Y, Hirata KI.

Echocardiography. 2017 Dec;34(12):1950-1952. doi: 10.1111/echo.13749. Epub 2017 Nov 6.

PMID:
29106750
12.

Water Soluble Vitamins Enhance the Growth of Microorganisms in Peripheral Parenteral Nutrition Solutions.

Omotani S, Tani K, Nagai K, Hatsuda Y, Mukai J, Myotoku M.

Int J Med Sci. 2017 Sep 19;14(12):1213-1219. doi: 10.7150/ijms.21424. eCollection 2017.

13.

Loss-of-function mutation in Mirta22/Emc10 rescues specific schizophrenia-related phenotypes in a mouse model of the 22q11.2 deletion.

Diamantopoulou A, Sun Z, Mukai J, Xu B, Fenelon K, Karayiorgou M, Gogos JA.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6127-E6136. doi: 10.1073/pnas.1615719114. Epub 2017 Jul 10.

14.

A Schizophrenia-Related Deletion Leads to KCNQ2-Dependent Abnormal Dopaminergic Modulation of Prefrontal Cortical Interneuron Activity.

Choi SJ, Mukai J, Kvajo M, Xu B, Diamantopoulou A, Pitychoutis PM, Gou B, Gogos JA, Zhang H.

Cereb Cortex. 2018 Jun 1;28(6):2175-2191. doi: 10.1093/cercor/bhx123.

15.

Effects of resistant dextrin for weight loss in overweight adults: a systematic review with a meta-analysis of randomized controlled trials.

Mukai J, Tsuge Y, Yamada M, Otori K, Atsuda K.

J Pharm Health Care Sci. 2017 May 16;3:15. doi: 10.1186/s40780-017-0084-9. eCollection 2017.

16.

Inverse associations of HDL cholesterol and oxidized HDL with d-dimer in patients with type 2 diabetes mellitus.

Ebara S, Marumo M, Yamabata C, Nishibe I, Soneda JI, Mukai J, Ohki M, Uchida K, Wakabayashi I.

Thromb Res. 2017 Jul;155:12-15. doi: 10.1016/j.thromres.2017.04.018. Epub 2017 Apr 20. No abstract available.

PMID:
28475944
17.

Cysteinylated transthyretin as a discriminator of cardiovascular risk in patients with diabetes mellitus.

Wakabayashi I, Marumo M, Nonaka D, Lee LJ, Mukai J, Ohki M, Tanaka K, Uchida K.

Clin Chim Acta. 2017 Jul;470:46-50. doi: 10.1016/j.cca.2017.04.015. Epub 2017 Apr 20.

PMID:
28434967
18.

Inhibition Mediated by Glycinergic and GABAergic Receptors on Excitatory Neurons in Mouse Superficial Dorsal Horn Is Location-Specific but Modified by Inflammation.

Takazawa T, Choudhury P, Tong CK, Conway CM, Scherrer G, Flood PD, Mukai J, MacDermott AB.

J Neurosci. 2017 Mar 1;37(9):2336-2348. doi: 10.1523/JNEUROSCI.2354-16.2017. Epub 2017 Jan 27.

19.

Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition.

Tamura M, Mukai J, Gordon JA, Gogos JA.

Neuron. 2016 Mar 2;89(5):1100-9. doi: 10.1016/j.neuron.2016.01.025. Epub 2016 Feb 18.

20.

Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Naito Y, Ichikawa H, Akagiri S, Uchiyama K, Takagi T, Handa O, Yasukawa Z, Tokunaga M, Ishihara N, Okubo T, Mukai J, Ohki M, Uchida K, Yoshikawa T.

J Clin Biochem Nutr. 2016 Jan;58(1):23-33. doi: 10.3164/jcbn.15-98. Epub 2015 Dec 8.

21.

Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome.

Piskorowski RA, Nasrallah K, Diamantopoulou A, Mukai J, Hassan SI, Siegelbaum SA, Gogos JA, Chevaleyre V.

Neuron. 2016 Jan 6;89(1):163-76. doi: 10.1016/j.neuron.2015.11.036.

22.

Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals.

Otsuki T, Maeda S, Mukai J, Ohki M, Nakanishi M, Yoshikawa T.

J Clin Biochem Nutr. 2015 Sep;57(2):151-5. doi: 10.3164/jcbn.15-27. Epub 2015 Jul 30.

23.

Prediction of acute encephalopathy with biphasic seizures and late reduced diffusion in patients with febrile status epilepticus.

Yokochi T, Takeuchi T, Mukai J, Akita Y, Nagai K, Obu K, Kakuma T, Matsuishi T.

Brain Dev. 2016 Feb;38(2):217-24. doi: 10.1016/j.braindev.2015.07.007. Epub 2015 Aug 1.

PMID:
26242200
24.

Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia.

Mukai J, Tamura M, Fénelon K, Rosen AM, Spellman TJ, Kang R, MacDermott AB, Karayiorgou M, Gordon JA, Gogos JA.

Neuron. 2015 May 6;86(3):680-95. doi: 10.1016/j.neuron.2015.04.003. Epub 2015 Apr 23.

25.

The BDNF Val66Met variant affects gene expression through miR-146b.

Hsu PK, Xu B, Mukai J, Karayiorgou M, Gogos JA.

Neurobiol Dis. 2015 May;77:228-37. doi: 10.1016/j.nbd.2015.03.004. Epub 2015 Mar 11.

26.

[Effect of lidocaine gargling on taste perception].

Mukai J, Tokuyama E, Miyatake N, Onohara M, Toyoda K, Haraguchi T, Uchida T.

Gan To Kagaku Ryoho. 2014 Nov;41(11):1413-6. Japanese.

PMID:
25434445
27.

Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation.

Tsubaki M, Komai M, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Biomed Sci. 2014 Feb 3;21:10. doi: 10.1186/1423-0127-21-10.

28.

By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.

Tsubaki M, Komai M, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

Leuk Res. 2014 Jan;38(1):121-30. doi: 10.1016/j.leukres.2013.10.017. Epub 2013 Oct 28.

PMID:
24239173
29.

The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion.

Fénelon K, Xu B, Lai CS, Mukai J, Markx S, Stark KL, Hsu PK, Gan WB, Fischbach GD, MacDermott AB, Karayiorgou M, Gogos JA.

J Neurosci. 2013 Sep 11;33(37):14825-39. doi: 10.1523/JNEUROSCI.1611-13.2013.

30.

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Exp Clin Cancer Res. 2013 Sep 5;32:62. doi: 10.1186/1756-9966-32-62.

31.

Apatite mineralization behavior on polyglutamic acid hydrogels in aqueous condition: effects of molecular weight.

Miyazaki T, Mukai J, Ishida E, Ohtsuki C.

Biomed Mater Eng. 2013;23(5):339-47. doi: 10.3233/BME-130758.

PMID:
23988706
32.

Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugs.

Tsubaki M, Komai M, Itoh T, Imano M, Sakamoto K, Shimaoka H, Ogawa N, Mashimo K, Fujiwara D, Takeda T, Mukai J, Sakaguchi K, Satou T, Nishida S.

Eur J Cancer. 2013 Nov;49(17):3708-17. doi: 10.1016/j.ejca.2013.07.010. Epub 2013 Aug 7.

PMID:
23932230
33.

LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes.

Fukui M, Tanaka M, Senmaru T, Nakanishi M, Mukai J, Ohki M, Asano M, Yamazaki M, Hasegawa G, Nakamura N.

Metabolism. 2013 Jul;62(7):935-8. doi: 10.1016/j.metabol.2013.01.018. Epub 2013 Feb 19.

PMID:
23433938
34.

Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.

Tsubaki M, Itoh T, Satou T, Imano M, Komai M, Ogawa N, Mukai J, Nishida S.

Biochem Pharmacol. 2013 Jan 15;85(2):163-72. doi: 10.1016/j.bcp.2012.10.009. Epub 2012 Oct 17.

PMID:
23085435
36.

S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95.

Ho GP, Selvakumar B, Mukai J, Hester LD, Wang Y, Gogos JA, Snyder SH.

Neuron. 2011 Jul 14;71(1):131-41. doi: 10.1016/j.neuron.2011.05.033.

37.

[A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].

Nakagawa M, Hamada A, Yoshihara Y, Ishizaka T, Fukushima M, Takahashi N, Sawada R, Mukai J.

Gan To Kagaku Ryoho. 2011 Feb;38(2):317-20. Review. Japanese.

PMID:
21368504
38.

Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex.

Fénelon K, Mukai J, Xu B, Hsu PK, Drew LJ, Karayiorgou M, Fischbach GD, Macdermott AB, Gogos JA.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4447-52. doi: 10.1073/pnas.1101219108. Epub 2011 Feb 28.

39.

Dietary whey hydrolysate with exercise alters the plasma protein profile: a comprehensive protein analysis.

Aoi W, Takanami Y, Kawai Y, Morifuji M, Koga J, Kanegae M, Mihara K, Yanohara T, Mukai J, Naito Y, Yoshikawa T.

Nutrition. 2011 Jun;27(6):687-92. doi: 10.1016/j.nut.2010.06.004. Epub 2010 Dec 9.

PMID:
21145706
40.

Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Fujita N, Nakanishi M, Mukai J, Naito Y, Ichida T, Kaito M, Yoshikawa T, Takei Y.

Mol Med. 2011 Jan-Feb;17(1-2):70-8. doi: 10.2119/molmed.2010.00124. Epub 2010 Oct 5.

41.

The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Drew LJ, Crabtree GW, Markx S, Stark KL, Chaverneff F, Xu B, Mukai J, Fenelon K, Hsu PK, Gogos JA, Karayiorgou M.

Int J Dev Neurosci. 2011 May;29(3):259-81. doi: 10.1016/j.ijdevneu.2010.09.007. Epub 2010 Oct 8. Review.

42.

Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion.

Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB, Karayiorgou M, Gogos JA.

Nat Neurosci. 2008 Nov;11(11):1302-10. doi: 10.1038/nn.2204. Epub 2008 Oct 5.

43.

Suppression of bitterness and improvement of palatability of commercial prednisolone powder.

Ishizaka T, Okada S, Tokuyama E, Mukai J, Uchida T.

Chem Pharm Bull (Tokyo). 2008 Oct;56(10):1395-9.

44.

Quality of twelve clarithromycin dry syrup formulations-bitterness, grittiness and uniformity of drug loading.

Ishizaka T, Okada S, Tokuyama E, Mukai J, Uchida T.

Chem Pharm Bull (Tokyo). 2008 Oct;56(10):1389-94.

45.

Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches.

Hsu R, Woodroffe A, Lai WS, Cook MN, Mukai J, Dunning JP, Swanson DJ, Roos JL, Abecasis GR, Karayiorgou M, Gogos JA.

PLoS One. 2007 Nov 28;2(11):e1234.

46.

Inhibitory effect of aroma on the bitterness of branched-chain amino acid solutions.

Mukai J, Tokuyama E, Ishizaka T, Okada S, Uchida T.

Chem Pharm Bull (Tokyo). 2007 Nov;55(11):1581-4.

47.

Lipids behavior and adverse effects for oral antidiabetic agents in patients with Type 2 diabetes treated with sulfonylureas alone based on systematic review.

Mukai J, Tada H, Watanabe Y, Miura M, Katsuyama S, Shoji T, Mohri K, Eto M, Suzuki T.

Yakugaku Zasshi. 2007 Oct;127(10):1747-56. Erratum in: Yakugaku Zasshi. 2010 Oct;130(10):1395. Mouri, Kiminori [corrected to Mohri, Kiminori].

48.

The suppression of enhanced bitterness intensity of macrolide dry syrup mixed with an acidic powder.

Ishizaka T, Okada S, Takemoto E, Tokuyama E, Tsuji E, Mukai J, Uchida T.

Chem Pharm Bull (Tokyo). 2007 Oct;55(10):1452-7.

49.

Genetic modulation of BDNF signaling affects the outcome of axonal competition in vivo.

Cao L, Dhilla A, Mukai J, Blazeski R, Lodovichi C, Mason CA, Gogos JA.

Curr Biol. 2007 Jun 5;17(11):911-21. Epub 2007 May 10.

50.

Bitterness suppression of BCAA solutions by L-ornithine.

Tokuyama E, Shibasaki T, Kawabe H, Mukai J, Okada S, Uchida T.

Chem Pharm Bull (Tokyo). 2006 Sep;54(9):1288-92.

Supplemental Content

Support Center